This interpretation aligns with clinical observations in carcinoid patients, where elevated serum serotonin shows high sensitivity (100%) but poor specificity (46%) for heart valve disease with no clear diagnostic cutoff23, whereas NT-proBNP, a marker of cardiac strain, often correlates better with carcinoid heart disease severity than systemic serotonin measurements24,25. This evidence concerns the gene NPPB and carcinoid tumor.